Logo image of GOVX

GEOVAX LABS INC (GOVX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GOVX - US3736786068 - Common Stock

0.207 USD
+0.04 (+21.05%)
Last: 1/2/2026, 8:00:01 PM
0.19 USD
-0.02 (-8.21%)
Pre-Market: 1/5/2026, 8:35:06 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GOVX. GOVX was compared to 530 industry peers in the Biotechnology industry. The financial health of GOVX is average, but there are quite some concerns on its profitability. GOVX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GOVX had negative earnings in the past year.
In the past year GOVX has reported a negative cash flow from operations.
In the past 5 years GOVX always reported negative net income.
GOVX had a negative operating cash flow in each of the past 5 years.
GOVX Yearly Net Income VS EBIT VS OCF VS FCFGOVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

GOVX's Return On Assets of -375.99% is on the low side compared to the rest of the industry. GOVX is outperformed by 92.83% of its industry peers.
Looking at the Return On Equity, with a value of -515.76%, GOVX is doing worse than 75.28% of the companies in the same industry.
Industry RankSector Rank
ROA -375.99%
ROE -515.76%
ROIC N/A
ROA(3y)-210.29%
ROA(5y)-163.35%
ROE(3y)-332.78%
ROE(5y)-290.99%
ROIC(3y)N/A
ROIC(5y)N/A
GOVX Yearly ROA, ROE, ROICGOVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GOVX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GOVX Yearly Profit, Operating, Gross MarginsGOVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

6

2. Health

2.1 Basic Checks

GOVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
GOVX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GOVX has more shares outstanding
GOVX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GOVX Yearly Shares OutstandingGOVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GOVX Yearly Total Debt VS Total AssetsGOVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

GOVX has an Altman-Z score of -39.61. This is a bad value and indicates that GOVX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GOVX (-39.61) is worse than 89.81% of its industry peers.
There is no outstanding debt for GOVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -39.61
ROIC/WACCN/A
WACC8.83%
GOVX Yearly LT Debt VS Equity VS FCFGOVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 3.57 indicates that GOVX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.57, GOVX is in line with its industry, outperforming 42.45% of the companies in the same industry.
GOVX has a Quick Ratio of 3.57. This indicates that GOVX is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 3.57, GOVX perfoms like the industry average, outperforming 44.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.57
Quick Ratio 3.57
GOVX Yearly Current Assets VS Current LiabilitesGOVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.57% over the past year.
The Revenue has grown by 8.52% in the past year. This is quite good.
Measured over the past years, GOVX shows a very strong growth in Revenue. The Revenue has been growing by 27.45% on average per year.
EPS 1Y (TTM)92.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.93%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y117.28%
Revenue growth 5Y27.45%
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, GOVX will show a very strong growth in Earnings Per Share. The EPS will grow by 31.50% on average per year.
GOVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 278.07% yearly.
EPS Next Y76.19%
EPS Next 2Y34.46%
EPS Next 3Y31.5%
EPS Next 5YN/A
Revenue Next Year-56.94%
Revenue Next 2Y-41.42%
Revenue Next 3Y278.07%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GOVX Yearly Revenue VS EstimatesGOVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2027 100M 200M 300M
GOVX Yearly EPS VS EstimatesGOVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GOVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GOVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GOVX Price Earnings VS Forward Price EarningsGOVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GOVX Per share dataGOVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as GOVX's earnings are expected to grow with 31.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.46%
EPS Next 3Y31.5%

More info and screens

0

5. Dividend

5.1 Amount

GOVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

GEOVAX LABS INC

NASDAQ:GOVX (1/2/2026, 8:00:01 PM)

Premarket: 0.19 -0.02 (-8.21%)

0.207

+0.04 (+21.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners8.59%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change6.03%
Market Cap6.15M
Revenue(TTM)3.35M
Net Income(TTM)-25.31M
Analysts81.82
Price Target9.49 (4484.54%)
Short Float %10.58%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5%
Min EPS beat(2)-14.69%
Max EPS beat(2)4.68%
EPS beat(4)3
Avg EPS beat(4)21.38%
Min EPS beat(4)-14.69%
Max EPS beat(4)61.7%
EPS beat(8)6
Avg EPS beat(8)-19.57%
EPS beat(12)8
Avg EPS beat(12)-15.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.06%
PT rev (3m)-6.06%
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)2.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS0.11
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -375.99%
ROE -515.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-210.29%
ROA(5y)-163.35%
ROE(3y)-332.78%
ROE(5y)-290.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.23%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.57
Quick Ratio 3.57
Altman-Z -39.61
F-Score4
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)108.76%
Cap/Depr(5y)249.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.93%
EPS Next Y76.19%
EPS Next 2Y34.46%
EPS Next 3Y31.5%
EPS Next 5YN/A
Revenue 1Y (TTM)8.52%
Revenue growth 3Y117.28%
Revenue growth 5Y27.45%
Sales Q2Q%-100%
Revenue Next Year-56.94%
Revenue Next 2Y-41.42%
Revenue Next 3Y278.07%
Revenue Next 5YN/A
EBIT growth 1Y-4.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-83000.3%
EBIT Next 3Y649.13%
EBIT Next 5YN/A
FCF growth 1Y-10.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.5%
OCF growth 3YN/A
OCF growth 5YN/A

GEOVAX LABS INC / GOVX FAQ

What is the ChartMill fundamental rating of GEOVAX LABS INC (GOVX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GOVX.


What is the valuation status for GOVX stock?

ChartMill assigns a valuation rating of 1 / 10 to GEOVAX LABS INC (GOVX). This can be considered as Overvalued.


How profitable is GEOVAX LABS INC (GOVX) stock?

GEOVAX LABS INC (GOVX) has a profitability rating of 0 / 10.


Can you provide the financial health for GOVX stock?

The financial health rating of GEOVAX LABS INC (GOVX) is 6 / 10.


What is the earnings growth outlook for GEOVAX LABS INC?

The Earnings per Share (EPS) of GEOVAX LABS INC (GOVX) is expected to grow by 76.19% in the next year.